Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Results of a fifty-gene breast cancer RNA subtype classifier applied to 167 colorectal cancer (CRC) patients
Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.20-20
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase 2 Quilt 88 trial of DAMP inducers combined with IL15 superagonist, N-803, and anti–PD-L1 NK cell therapy more than doubles historical overall survival in patients with third- to sixth-line advanced pancreatic cancer
Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4147-4147
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Promising survival and disease control in third-line or greater metastatic or locally advanced pancreatic cancer patients following chemo-radiation and novel combination of aldoxorubicin, N-803 IL-15 superagonist, and PDL1- NK cell therapy
Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.582-582
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Quilt-3.064: An open-label phase I study of PD-L1 t-haNK in subjects with locally advanced or metastatic solid cancers
Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS3152-TPS3152
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Overall survival in patients with metastatic or locally advanced pancreatic cancer following chemoradiation with novel combination of aldoxorubicin, N-803 IL-15 superagonist, and PDL1- NK cell therapy
Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.720-720
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Clinical trial screening of CDKN2A genomic alterations in patients with pancreatic cancer and hepatobiliary cancers requires greater precision than somatic sequencing alone
Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.287-287
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Innate and adaptive immunotherapy: An orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with third line or greater metastatic pancreatic cancer
Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15787-e15787
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Immunotherapy combining NK and T cell activation with IL-15 super agonist (N-803), off-the-shelf high-affinity CD16 NK (haNK) or PDL1 targeted haNK and checkpoint inhibitor in relapsed/refractory advanced pancreatic cancer
Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15015-e15015
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A retrospective, single-institution experience of resected ampullary adenocarcincoma: predictors of clinical outcome
Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15229-e15229
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Three-fold overestimation of tumor mutation burden using 248 gene panel versus whole exome
Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.12117-12117
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Correlation between circulating cell-free RNA biomarkers and response during combination immunotherapy in previously refractory metastatic TNBC patients
Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14027-e14027
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
NANT cancer vaccine an orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with third line or greater metastatic pancreatic cancer
Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS463-TPS463
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139)
Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.208-208
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA)
Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4008-4008
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Interim results of a randomized phase II study of PEGPH20 added to nab-paclitaxel/gemcitabine in patients with stage IV previously untreated pancreatic cancer
Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.439-439
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase II study of MK-2206, an allosteric inhibitor of AKT as second-line therapy for advanced gastric and gastroesophageal junction (GEJ) cancer: A SWOG Cooperative Group trial (S1005)
Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4041-4041
2014
Volltextzugriff (PDF)
1 – 16 von 16
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen